These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 2536917)
1. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
2. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288 [TBL] [Abstract][Full Text] [Related]
3. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Gazdar AF; Carney DN; Nau MM; Minna JD Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258 [TBL] [Abstract][Full Text] [Related]
4. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922 [TBL] [Abstract][Full Text] [Related]
5. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE; Bepler G; Kubasch M; Havemann K Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028 [TBL] [Abstract][Full Text] [Related]
6. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535 [TBL] [Abstract][Full Text] [Related]
8. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051 [TBL] [Abstract][Full Text] [Related]
10. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061 [TBL] [Abstract][Full Text] [Related]
11. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814 [TBL] [Abstract][Full Text] [Related]
12. Expression of the c-myb oncogene in human small cell lung carcinoma. Griffin CA; Baylin SB Cancer Res; 1985 Jan; 45(1):272-5. PubMed ID: 2578097 [TBL] [Abstract][Full Text] [Related]
13. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339 [TBL] [Abstract][Full Text] [Related]
14. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines. Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569 [TBL] [Abstract][Full Text] [Related]
15. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer. Bepler G; Jaques G; Havemann K; Koehler A; Johnson BE; Gazdar AF Cancer Res; 1987 Apr; 47(7):1883-91. PubMed ID: 3028617 [TBL] [Abstract][Full Text] [Related]
16. [Recent progress in the biology of small cell bronchial carcinoma]. Thomas F; Arriagada R; Le Chevalier T; Poupon MF Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257 [TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Graziano SL; Cowan BY; Carney DN; Bryke CR; Mitter NS; Johnson BE; Mark GE; Planas AT; Catino JJ; Comis RL Cancer Res; 1987 Apr; 47(8):2148-55. PubMed ID: 3030544 [TBL] [Abstract][Full Text] [Related]
18. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971 [TBL] [Abstract][Full Text] [Related]
19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]